Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct:138:110509.
doi: 10.1016/j.contraception.2024.110509. Epub 2024 Jun 1.

State variations in insertion of long-acting reversible contraception during delivery hospitalization

Keshob Sharma  1 , Shanna Cox  2 , Lisa Romero  2 , Donatus Ekwueme  3 , Maura Whiteman  2 , Charlan Kroelinger  2 , Lijing Ouyang  2
Affiliations

State variations in insertion of long-acting reversible contraception during delivery hospitalization

Keshob Sharma et al. Contraception. 2024 Oct.

Abstract

Objectives: This study aimed to describe immediate postpartum long-acting reversible contraception (IPP LARC) insertion rates during delivery hospitalizations at the state level and by payor type.

Study design: This is a cross-sectional study of 26 states and District of Columbia using 2020 State Inpatient Database.

Results: In 2020, IPP LARC insertion rates varied widely by states, ranging from 2.55 to 637.25 per 10,000 deliveries. Rates were higher for deliveries with Medicaid as primary expected payor than with private insurance in all states but District of Columbia.

Conclusions: Rates of IPP LARC insertion varied in 2020 by state and were higher for deliveries with Medicaid as primary expected payor.

Keywords: Contraception; Deliveries; Intrauterine device; Long-acting reversible contraception; Medicaid.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: The authors report no conflict of interest.

Similar articles

See all similar articles

References

    1. Kroelinger CD, Morgan IA, Desisto CL, Estrich C, Waddell LF, MacKie C, et al. State-identified implementation strategies to increase uptake of immediate postpartum long-acting reversible contraception policies. J Womens Health 2019;28:346–56. 10.1089/JWH.2018.7083 - DOI - PMC - PubMed
    1. Fang NZ, Westhoff CL. Update on incidence of inpatient tubal ligation and long-acting reversible contraception in the United States. Am J Obstet Gynecol 2022;227:477.e1–7. 10.1016/j.ajog.2022.05.021 - DOI - PubMed
    1. White K, Potter JE, Hopkins K, Grossman D. Variation in postpartum contraceptive method use: results from the Pregnancy Risk Assessment Monitoring System (PRAMS). Contraception 2014;89:57–62. 10.1016/j.contraception.2013.10.005 - DOI - PMC - PubMed
    1. Bruce K, Stefanescu A, Romero L, Okoroh E, Cox S, Kieltyka L, et al. Trends in postpartum contraceptive use in 20 U.S. states and jurisdictions: the Pregnancy Risk Assessment Monitoring System, 2015–2018. Women’s Health Issues 2023;33:133–41. 10.1016/j.whi.2022.10.002 - DOI - PMC - PubMed
    1. Healthcare Cost and Utilization Project (HCUP). State Inpatient Databases (SID). Agency for Healthcare Research and Quality; 2020. 〈www.hcup-us.ahrq.gov/sidoverview.jsp〉. - PubMed

MeSH terms

Substances